The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: A validation study

Veterinary Pathology

Volumn 46, Issue 2, 2009, Pages 362-364

  Elston, Lilian B ^a   Sueiro, Felipe A R ^b   Cavalcanti, Josemara N ^c   Metze, Konradin ^d  

^a PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Veterinary School   (Brazil)

^c UNIVERSITY OF SPLIT   (Croatia)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; CELL PROLIFERATION; DOG; DOG DISEASE; LETTER; PATHOLOGY; PREDICTIVE VALUE; URTICARIA PIGMENTOSA;

ANIMALS; CELL PROLIFERATION; DOG DISEASES; DOGS; MASTOCYTOSIS, CUTANEOUS; PREDICTIVE VALUE OF TESTS;

EID: 67650928631     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.08-VP-0225-M-LTR     Document Type: Letter

References (14)

1. Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K: The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol 28:55-59, 2006
2. Calonego SB, Barjas-Castro ML, Metze K, Pereira FG, Lorand-Metze I: The influence of storage and leukocyte depletion on the antigen densities of FY1, FY2, MNS3 and MNS4 measured by flow cytometry. Transfus Apher Sci 38:101-107, 2008
3. Lorand-Metze I, Meira DG, Lima CS, Vassallo J, Metze K: The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia. Haematologica 84:564-565, 1999
4. Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K: Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 28:587-594, 2004
5. Luong RH, Baer KE, Craft DM, Ettinger SN, Scase TJ, Bergman PJ: Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas. Vet Pathol 43:622-631, 2006
6. Metze K: Dichotomization of continuous data: a pitfall in prognostic factor studies. Pathol Res Pract 204:213-214, 2008
7. Metze K, Adam RL: Pitfalls in prognostic factor studies. Braz J Med Biol Res 38:141-143, 2005
8. Metze K, Chiari AC, Andrade FL, Lorand-Metze I: Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia. Hematol Cell Ther 41:205-210, 1999
9. Metze K, Lobo AM, Lorand-Metze I: Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lymphocytic leukemia. Int J Cancer 89:440-443, 2000
10. Metze K, Oliveira GB, Pereira FG, Adam RL, Lorand-Metze I: Spontaneous apoptosis in chronic lymphocytic leukemia is not an independent prognostic factor for stability of disease when compared with combined AgNOR and TTM scores. Cell Oncol 27:199-201, 2005
11. Oliveira GB, Pereira FG, Metze K, Lorand-Metze I: Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters. Cytometry 46:329-335, 2001
12. Romansik EM, Reilly CM, Kass PH, Moore PF, London CA: Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44:335-341, 2007
13. Sánchez J, Ramirez GA, Buendia AJ, Vilafranca M, Martinez CM, Altimira J, Navarro JA: Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation. Vet Pathol 44:676-682, 2007
14. Spangler WL, Kass PH: The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol 43:136-149, 2006